Related Experiment Videos
Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry
The Journal of Pharmacology and Experimental Therapeutics
|February 1, 1981
Summary
This study identified two types of benzodiazepine receptors in the brain using radiohistochemistry. Type 1 receptors show high affinity for triazolopyridazines, while Type 2 receptors have low affinity, aiding in understanding drug differences.
Area of Science:
- Neuroscience
- Pharmacology
- Receptor Binding Assays
Background:
- Benzodiazepine receptor binding studies suggest at least two distinct receptor subtypes exist.
- A key difference between these subtypes is their varying affinity for triazolopyridazines.
Purpose of the Study:
- To investigate the regional distribution of two different benzodiazepine receptor subtypes.
- To differentiate between high-affinity and low-affinity triazolopyridazine binding sites in the brain.
Main Methods:
- Utilized light microscopic radiohistochemistry to map receptor localization.
- Employed [3H]flunitrazepam for overall benzodiazepine receptor labeling.
- Used CL218,872, a triazolopyridazine, to selectively displace binding to high-affinity sites.
Main Results:
- Autoradiographs revealed differential effects of CL218,872 across brain regions, indicating distinct receptor populations.
- Type 1 receptors (high triazolopyridazine affinity) were found in the cerebellum, globus pallidus, and cerebral cortex.
- Type 2 receptors (low triazolopyridazine affinity) were localized to the superior colliculus, caudate-putamen, and dentate gyrus.
Conclusions:
- The distinct regional localization supports the existence of at least two benzodiazepine receptor subtypes.
- Findings may elucidate physiological differences between benzodiazepine and triazolopyridazine drugs.
- Identified specific brain regions for future research on these receptor subtypes.